410 related articles for article (PubMed ID: 23928230)
21. Case report of drug rash with eosinophilia and systemic symptoms demonstrating human herpesvirus-6 reactivation.
Ferrero NA; Pearson KC; Zedek DC; Morrell DS
Pediatr Dermatol; 2013; 30(5):608-13. PubMed ID: 24016284
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS).
Ogawa K; Morito H; Hasegawa A; Miyagawa F; Kobayashi N; Watanabe H; Sueki H; Tohyama M; Hashimoto K; Kano Y; Shiohara T; Ito K; Fujita H; Aihara M; Asada H
Br J Dermatol; 2014 Aug; 171(2):425-7. PubMed ID: 24601914
[No Abstract] [Full Text] [Related]
23. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
Mitsui Y; Shinkuma S; Nakamura-Nishimura Y; Ommori R; Ogawa K; Miyagawa F; Mori Y; Tohyama M; Asada H
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063
[TBL] [Abstract][Full Text] [Related]
24. Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Tohyama M; Hashimoto K; Oda F; Namba C; Sayama K
J Dermatol; 2020 May; 47(5):476-482. PubMed ID: 32162382
[TBL] [Abstract][Full Text] [Related]
25. Drug-induced hypersensitivity syndrome with human herpesvirus-6 reactivation.
Riyaz N; Sarita S; Arunkumar G; Sabeena S; Manikoth N; Sivakumar CP
Indian J Dermatol Venereol Leprol; 2012; 78(2):175-7. PubMed ID: 22421649
[TBL] [Abstract][Full Text] [Related]
26. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
27. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
28. Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS).
Mizukawa Y; Kimishima M; Aoyama Y; Shiohara T
Int J Infect Dis; 2020 Nov; 100():239-246. PubMed ID: 32891735
[TBL] [Abstract][Full Text] [Related]
29. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
[TBL] [Abstract][Full Text] [Related]
30. Relationship between beta-herpesviruses reactivation and development of complications after autologous peripheral blood stem cell transplantation.
Chapenko S; Trociukas I; Donina S; Chistyakov M; Sultanova A; Gravelsina S; Lejniece S; Murovska M
J Med Virol; 2012 Dec; 84(12):1953-60. PubMed ID: 23080502
[TBL] [Abstract][Full Text] [Related]
31. Toxic epidermal necrolysis due to zonisamide associated with reactivation of human herpesvirus 6.
Teraki Y; Murota H; Izaki S
Arch Dermatol; 2008 Feb; 144(2):232-5. PubMed ID: 18283181
[TBL] [Abstract][Full Text] [Related]
32. Trichloroethylene Hypersensitivity Syndrome: Should Be Considered When Diagnosing DRESS Syndrome.
Kang YJ; Lee J; Ahn J; Park S; Shin MY; Lee HW
J Korean Med Sci; 2018 Apr; 33(14):e106. PubMed ID: 29607632
[TBL] [Abstract][Full Text] [Related]
33. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis.
Michel F; Navellou JC; Ferraud D; Toussirot E; Wendling D
Joint Bone Spine; 2005 Jan; 72(1):82-5. PubMed ID: 15681256
[TBL] [Abstract][Full Text] [Related]
34. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
[TBL] [Abstract][Full Text] [Related]
35. Codeine phosphate-induced hypersensitivity syndrome.
Enomoto M; Ochi M; Teramae K; Kamo R; Taguchi S; Yamane T
Ann Pharmacother; 2004 May; 38(5):799-802. PubMed ID: 15010521
[TBL] [Abstract][Full Text] [Related]
36. Reactivation of Human Herpes Virus-6 in the Renal Tissue of a Patient with Drug-induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Hagiya H; Iwamuro M; Tanaka T; Hasegawa K; Hanayama Y; Kimura M; Otsuka F
Intern Med; 2016; 55(13):1769-74. PubMed ID: 27374681
[TBL] [Abstract][Full Text] [Related]
37. The interferon-γ-induced protein 10/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms.
Yang CW; Cho YT; Hsieh YC; Hsu SH; Chen KL; Chu CY
Br J Dermatol; 2020 Nov; 183(5):909-919. PubMed ID: 32037509
[TBL] [Abstract][Full Text] [Related]
38. Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
Watanabe H
J Immunol Res; 2018; 2018():5163129. PubMed ID: 29744372
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients.
Fujita A; Ihira M; Suzuki R; Enomoto Y; Sugiyama H; Sugata K; Suga S; Asano Y; Yagasaki H; Kojima S; Matsumoto K; Kato K; Yoshikawa T
J Infect; 2008 Sep; 57(3):241-8. PubMed ID: 18662831
[TBL] [Abstract][Full Text] [Related]
40. Skin recruitment of monomyeloid precursors involves human herpesvirus-6 reactivation in drug allergy.
Hashizume H; Fujiyama T; Kanebayashi J; Kito Y; Hata M; Yagi H
Allergy; 2013; 68(5):681-9. PubMed ID: 23573902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
